Skip to content
A Blog by Biocon

A Blog by Biocon

  • Home
  • About Us
  • Biocon Biologics
    • Biosimilars
    • Biocon Biologics @ IDF Congress 2019
      • Speaker Profiles
    • Itolizumab (ALZUMAb®) : Highly Promising Therapy for Cytokine Release Syndrome (CRS) in COVID-19
  • Healthcare
  • Innovation
  • Disease Epidemiology
  • Vodcast
  • Bioconites Corner
    • Work From Home
    • Campaigns
      • Har Ghar Tiranga
      • Mother’s Day
      • Lupus Day
  • Policy
  • Comments Policy
  • Contact

Month: March 2018

March 14, 2018 Biocon Disease Management

Rare Diseases – A Huge Unmet Need in Diagnosis, Treatment and Management

A Disease may be Rare but Hope should not be!

March 8, 2018March 8, 2018 Biocon General

Wonder Women of Biocon

On International Women's Day, Biocon salutes the indomitable spirit of it's Wonder Women!

Biocon Employees come together to sing our National Anthem to mark 75th Independence Day.

Itolizumab: Highly Promising Therapy for Cytokine Release Syndrome (CRS) in COVID-19

DCGI Approval for emergency use of Itolizumab in treatment of Covid-19

Follow Biocon Biologics

BBL-X
BBL-Li
BBL-fb
BBL-Inst

Follow Biocon

Search

Biocon Limited

20th KM, Hosur Road,
Electronic City,
Bangalore, India - 560 100
Email: contact.us@biocon.com
+91 80 2808 2808 / 91 80 4014 4014

Archives

DISCLAIMER

Please read our Disclaimer and Comments Policy before engaging on our blog!

Create a website or blog at WordPress.com
  • Subscribe Subscribed
    • A Blog by Biocon
    • Join 121 other subscribers
    • Already have a WordPress.com account? Log in now.
    • A Blog by Biocon
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar

Loading Comments...